{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T20:26:16Z","timestamp":1788639976333,"version":"build-2803163510"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Graves\u2019 disease is a prevalent thyroid disorder and is the primary cause of hyperthyroidism. Significant progress has been made in understanding the epidemiology, pathogenesis, diagnosis, treatment, and prognosis of this disease. However, bibliometric analyses on Graves\u2019 disease are lacking. We aimed to comprehensively summarize the research, progression, and focal points of Graves\u2019 disease through data mining and integrated analysis of the existing literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrieved relevant literature on Graves\u2019 disease from 2003 to 2023 from the Web of Science database. We performed bibliometric analysis using CiteSpace and the R package Bibliometrix.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We identified 10,901 publications from 132 countries, with a steady rise in the number of publications over the past 5 years. The US leads in publication volume, with the University of California System being the primary contributing institution. The journal Thyroid had the highest publication output, while the Journal of Clinical Endocrinology and Metabolism was the most frequently cited. These publications involved 2305 authors, with Antonelli Alessandro and Smith Terry being the most prolific. The most frequently cited articles were the \u201c2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis\u201d and the \u201cThyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy.\u201d Analysis of the bursts of cited references, keywords, and their clustering revealed that research on Graves\u2019 disease predominantly centers on clinical management, thyroid-stimulating hormone receptors, thyroid hormones, autoimmunity and inflammation, Graves\u2019 ophthalmopathy, thyroid nodules, and thyroid cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This is the first comprehensive bibliometric study to summarize progress and trends in Graves\u2019 disease research. These results highlight recent research hotspots and promising directions, thereby providing a valuable reference for other scholars.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037963","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T18:05:14Z","timestamp":1718388314000},"page":"e37963","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Global research landscape and emerging trends in Graves\u2019 disease: A bibliometric analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4795-0897","authenticated-orcid":false,"given":"Yan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Thyropathy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"},{"name":"Clinical Lab, Sunsimiao Hospital, Beijing University of Chinese Medicine, Tongchuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thyropathy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"},{"name":"Department of Thyropathy, Sunsimiao Hospital, Beijing University of Chinese Medicine, Tongchuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjian","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First People\u2019s Hospital of Mudanjiang City, Mudanjiang, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical lab, Tongchuan People\u2019s Hospital, Tongchuan, Shanxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical lab, Tongchuan People\u2019s Hospital, Tongchuan, Shanxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Thyropathy, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China"},{"name":"Department of Thyropathy, Sunsimiao Hospital, Beijing University of Chinese Medicine, Tongchuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Thyropathy, Sunsimiao Hospital, Beijing University of Chinese Medicine, Tongchuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ando.2018.09.002","article-title":"Graves\u2019 disease: introduction, epidemiology, endogenous and environmental pathogenic factors.","volume":"79","author":"W\u00e9meau","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"101388","DOI":"10.1016\/j.beem.2020.101388","article-title":"Graves\u2019 disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy.","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/archdischild-2022-323905","article-title":"Graves\u2019 disease: moving forwards.","volume":"108","author":"Lane","year":"2023","journal-title":"Arch Dis Child"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"101387","DOI":"10.1016\/j.beem.2020.101387","article-title":"Graves\u2019 disease: epidemiology, genetic and environmental risk factors and viruses.","volume":"34","author":"Antonelli","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"Suppl 3","key":"R5-20250503","doi-asserted-by":"crossref","first-page":"S431","DOI":"10.33549\/physiolres.934018","article-title":"Genetic predictors of the development and recurrence of Graves\u2019 disease.","volume":"67","author":"Vejrazkova","year":"2018","journal-title":"Physiol Res"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.","volume":"35","author":"McLachlan","year":"2014","journal-title":"Endocr Rev"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IOP.0000000000001052","article-title":"Thyrotropin receptor antibodies-an overview.","volume":"34","author":"Kotwal","year":"2018","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/a-0723-9023","article-title":"Thyrotropin receptor blocking antibodies.","volume":"50","author":"Diana","year":"2018","journal-title":"Horm Metab Res"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1210\/clinem\/dgz292","article-title":"Prospective trial of functional thyrotropin receptor antibodies in Graves disease.","volume":"105","author":"Kahaly","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ando.2011.03.013","article-title":"Twins as a tool for evaluating the influence of genetic susceptibility in thyroid autoimmunity.","volume":"72","author":"Brix","year":"2011","journal-title":"Ann Endocrinol (Paris)"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2265.2011.04318.x","article-title":"Twin studies as a model for exploring the aetiology of autoimmune thyroid disease.","volume":"76","author":"Brix","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/clinem\/dgab763","article-title":"Adjuvant rituximab-exploratory trial in young people with Graves disease.","volume":"107","author":"Cheetham","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/1008-682X.171582","article-title":"Bibliometrics: tracking research impact by selecting the appropriate metrics.","volume":"18","author":"Agarwal","year":"2016","journal-title":"Asian J Androl"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: an R-tool for comprehensive science mapping analysis.","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"e24831","DOI":"10.2196\/24831","article-title":"Overview of graves ophthalmopathy literature from 1999 to 2019: bibliometric analysis.","volume":"10","author":"Cao","year":"2021","journal-title":"Interact J Med Res"},{"key":"R17-20250503","first-page":"590","article-title":"Trends in Graves\u2019 orbitopathy research in the past two decades: a bibliometric analysis.","volume":"85","author":"Elubous","year":"2022","journal-title":"Arq Bras Oftalmol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1277739","DOI":"10.3389\/fendo.2023.1277739","article-title":"Mapping the path towards novel treatment strategies: a bibliometric analysis of Hashimoto\u2019s thyroiditis research from 1990 to 2023.","volume":"14","author":"Guo","year":"2023","journal-title":"Front Endocrinol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"953465","DOI":"10.3389\/fimmu.2022.953465","article-title":"Emerging trends and hot spots in autoimmune thyroiditis research from 2000 to 2022: a bibliometric analysis.","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1252389","DOI":"10.3389\/fendo.2023.1252389","article-title":"Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.","volume":"14","author":"Song","year":"2023","journal-title":"Front Endocrinol"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1119915","DOI":"10.3389\/fonc.2023.1119915","article-title":"A bibliometric analysis based on Web of Science from 2012 to 2021: current situation, hot spots, and global trends of medullary thyroid carcinoma.","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves\u2019 orbitopathy guidelines for the management of Graves\u2019 orbitopathy.","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease.","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of graves\u2019 hyperthyroidism.","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy.","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves\u2019 ophthalmopathy.","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease.","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy.","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders.","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"key":"R32-20250503","first-page":"913","article-title":"History, purposes and characteristics of medical journals.","volume":"8","author":"Reyes","year":"2018","journal-title":"Rev Med Chil"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"e1918007","DOI":"10.1001\/jamanetworkopen.2019.18007","article-title":"A bibliometric analysis of top-cited journal articles in obstetrics and gynecology.","volume":"2","author":"Brandt","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"1237864","DOI":"10.3389\/fendo.2023.1237864","article-title":"Knowledge mapping and global trends in the field of low-intensity pulsed ultrasound and endocrine and metabolic diseases: a bibliometric and visual analysis from 2012 to 2022.","volume":"14","author":"Chu","year":"2023","journal-title":"Front Endocrinol"},{"key":"R35-20250503","first-page":"e21014","article-title":"Treatment of Graves\u2019 disease associated with severe neutropenia.","volume":"14","author":"Laidi","year":"2022","journal-title":"Cureus"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41433-018-0267-0","article-title":"A history of Graves and St. John\u2019s.","volume":"33","author":"Williams","year":"2019","journal-title":"Eye (Lond)"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"939433","DOI":"10.3389\/fimmu.2022.939433","article-title":"Knowledge mapping of exosomes in autoimmune diseases: a bibliometric analysis (2002\u20132021).","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.beem.2018.03.014","article-title":"Diagnosis and management of hyperthyroidism from prenatal life to adolescence.","volume":"32","author":"L\u00e9ger","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/jpem.2011.093","article-title":"High frequency of cardiac and behavioral complaints as presenting symptoms of hyperthyroidism in children.","volume":"24","author":"Loomba-Albrecht","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"101414","DOI":"10.1016\/j.beem.2020.101414","article-title":"Management of thyrotoxicosis during pregnancy.","volume":"34","author":"Andersen","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00404-022-06774-z","article-title":"Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves\u2019 disease.","volume":"308","author":"Guo","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease.","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves disease: a global overview.","volume":"9","author":"Bartalena","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"e210073","DOI":"10.1530\/ETJ-21-0073","article-title":"2022 European Thyroid Association Guideline for the management of pediatric Graves\u2019 disease.","volume":"11","author":"Mooij","year":"2022","journal-title":"Eur Thyroid J"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. The thyroid study Group.","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"R46-20250503","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2015.16535","article-title":"Management of Graves disease: a review.","volume":"314","author":"Burch","year":"2015","journal-title":"JAMA"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1210\/clinem\/dgab700","article-title":"Does radioactive iodine therapy for hyperthyroidism cause cancer?","volume":"107","author":"Kim","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jamainternmed.2019.5123","article-title":"Safety of the use of radioactive iodine in patients with hyperthyroidism-reply.","volume":"179","author":"Kitahara","year":"2019","journal-title":"JAMA Intern Med"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SLA.0000000000001688","article-title":"Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes?","volume":"265","author":"Adam","year":"2017","journal-title":"Ann Surg"},{"key":"R50-20250503","first-page":"39","article-title":"Thyroidectomy in pediatric patients with Graves\u2019 disease: a systematic review of postoperative morbidity.","volume":"10","author":"Zaat","year":"2021","journal-title":"Eur Thyroid J"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: a review.","volume":"330","author":"Lee","year":"2023","journal-title":"JAMA"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41586-022-05173-3","article-title":"Hormone- and antibody-mediated activation of the thyrotropin receptor.","volume":"609","author":"Duan","year":"2022","journal-title":"Nature"},{"key":"R53-20250503","first-page":"846","article-title":"Autoantibody mimicry of hormone action at the thyrotropin receptor.","volume":"609","author":"Faust","year":"2022","journal-title":"Nature"},{"issue":"Pt A","key":"R54-20250503","doi-asserted-by":"crossref","first-page":"110873","DOI":"10.1016\/j.intimp.2023.110873","article-title":"TSHR-based chimeric antigen receptor T cell specifically deplete auto-reactive B lymphocytes for treatment of autoimmune thyroid disease.","volume":"124","author":"Duan","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/antib12030048","article-title":"The usefulness of thyroid antibodies in the diagnostic approach to autoimmune thyroid disease.","volume":"12","author":"Vargas-Uricoechea","year":"2023","journal-title":"Antibodies (Basel)"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3390\/diagnostics13162707","article-title":"Evaluation of the Abbott Alinity I thyroid-stimulating hormone receptor antibody (TRAb) chemiluminescent microparticle immunoassay (CMIA).","volume":"13","author":"Lee","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"323","DOI":"10.23736\/S0391-1977.17.02791-2","article-title":"TSH-receptor autoantibodies: pathophysiology, assay methods, and clinical applications.","volume":"43","author":"Ehlers","year":"2018","journal-title":"Minerva Endocrinol"},{"key":"R58-20250503","first-page":"e31233","article-title":"Utility of antibodies in the diagnoses of thyroid diseases: a review article.","volume":"14","author":"Gupta","year":"2022","journal-title":"Cureus"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/0004563217700655","article-title":"Stimulating TSH receptor autoantibodies immunoassay: analytical evaluation and clinical performance in Graves\u2019 disease.","volume":"55","author":"Autilio","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/bmm-2022-0666","article-title":"Establishment and analytical performance of light-initiated chemiluminescence assay method for detecting thyrotropin receptor antibody.","volume":"17","author":"Sun","year":"2023","journal-title":"Biomark Med"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"117505","DOI":"10.1016\/j.cca.2023.117505","article-title":"Stability of TSH receptor antibody concentrations and comparability of its immunoassays.","volume":"548","author":"Jansen","year":"2023","journal-title":"Clin Chim Acta"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1871530323666230908143521","article-title":"Interleukin (IL)-23, IL-31, and IL-33 play a role in the course of autoimmune endocrine diseases.","volume":"24","author":"Janyga","year":"2023","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","article-title":"Interleukin-23: as a drug target for autoimmune inflammatory diseases.","volume":"135","author":"Tang","year":"2012","journal-title":"Immunology"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","article-title":"Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview.","volume":"12","author":"Schinocca","year":"2021","journal-title":"Front Immunol"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases.","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin Immunopathol"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature09447","article-title":"Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling.","volume":"467","author":"Ghoreschi","year":"2010","journal-title":"Nature"},{"key":"R67-20250503","doi-asserted-by":"crossref","first-page":"1225494","DOI":"10.3389\/fendo.2023.1225494","article-title":"Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases.","volume":"14","author":"Kravchenko","year":"2023","journal-title":"Front Endocrinol"},{"key":"R68-20250503","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12020-023-03490-9","article-title":"A role of NR4A2 in Graves\u2019 disease: regulation of Th17\/Treg.","volume":"83","author":"Zhao","year":"2023","journal-title":"Endocrine"},{"key":"R69-20250503","doi-asserted-by":"crossref","first-page":"101743","DOI":"10.1016\/j.beem.2023.101743","article-title":"Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms.","volume":"37","author":"Wang","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R70-20250503","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.3390\/ijms24076835","article-title":"Characterizing the interplay of lymphocytes in Graves\u2019 disease.","volume":"24","author":"Hansen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R71-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0889-8529(05)70299-1","article-title":"The pathogenesis of Graves\u2019 disease.","volume":"27","author":"McIver","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R72-20250503","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4274\/tjo.80688","article-title":"Thyroid-associated ophthalmopathy.","volume":"47","author":"\u015eahli","year":"2017","journal-title":"Turk J Ophthalmol"},{"key":"R73-20250503","first-page":"2557","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.","volume":"84","author":"Valyasevi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R74-20250503","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/thy.2012.0568","article-title":"Cancer risk in patients with Graves\u2019 disease: a nationwide cohort study.","volume":"23","author":"Chen","year":"2013","journal-title":"Thyroid"},{"key":"R75-20250503","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5114\/aoms.2018.81136","article-title":"Frequency of thyroid nodules and thyroid cancer in thyroidectomized patients with Graves\u2019 disease.","volume":"16","author":"Keskin","year":"2019","journal-title":"Arch Med Sci"},{"key":"R76-20250503","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2174\/1871530321666201230111911","article-title":"Thyroid cancer and nodules in Graves\u2019 disease: a single center experience.","volume":"21","author":"Casella","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"R77-20250503","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12902-022-01116-1","article-title":"Graves\u2019 disease and papillary thyroid carcinoma: case report and literature review of a single academic center.","volume":"22","author":"Arosemena","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R78-20250503","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.amjoto.2014.04.013","article-title":"Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves\u2019 disease and euthyroid goiter, Cleveland Clinic experience.","volume":"35","author":"Ergin","year":"2014","journal-title":"Am J Otolaryngol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:41:11Z","timestamp":1746319271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":77,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037963","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}